The Evaluation of Risk Factors Associated With Relapse and Recurrence of Borderline Ovarian Tumors With Long-Term Follow-up

被引:26
|
作者
Sobiczewski, Piotr [1 ]
Kupryjanczyk, Jolanta [2 ]
Michalski, Wojciech [3 ]
Spiewankiewicz, Beata [1 ]
机构
[1] Maria Sklodowska Curie Mem Canc Ctr, Dept Gynecol Oncol, PL-02781 Warsaw, Poland
[2] Maria Sklodowska Curie Mem Canc Ctr, Dept Pathol & Lab Diagnost, Warsaw, Poland
[3] Maria Sklodowska Curie Mem Canc Ctr, Bioinformat & Biostat Unit, Warsaw, Poland
关键词
Borderline ovarian tumors; Relapse; Risk factors; PROGNOSTIC-FACTORS; PERITONEAL IMPLANTS; INVASIVE-CARCINOMA; MICROINVASION; MANAGEMENT; LAPAROSCOPY; SURVIVAL; SURGERY; IMPACT; COHORT;
D O I
10.1097/IGC.0000000000000722
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The goal was to analyze the risk factors of relapse and to compare the type of recurrence in patients with borderline tumors treated and followed up in Oncologic Center in Warsaw. Materials and Methods: This is a retrospective-prospective cohort study of 307 patients with confirmed borderline ovarian tumors treated in the Maria Sklodowska-Curie Memorial Cancer Center in Warsaw between 1994 and 2010. Univariate and multivariate analysis as well as Kaplan-Meier estimates were used to explore the impact of different covariates on progression-free survival. The analysis included the following potential prognostic factors: age, CA 125 value, stage according to classification of the International Federation of Gynecology and Obstetrics (FIGO), methods and radicality of operation, staging, tumor capsule rupture, histopathology, implants, ascites, and microinvasion. The analysis of relapses was also performed. Results: Univariate analysis showed the negative impact of 2 factors on progression-free survival: FIGO II/III (implants) (P = 0.011) and ascites (P = 0.027). The multivariate analyses showed the detrimental effect of FIGO Ic (HR, 2.63; 95% confidence interval [CI], 1.12-6.17, P = 0.027), FIGO II or III (implants) (HR, 3.67; 95% CI, 1.56-8.61, P = 0.003), and incomplete staging (HR, 3.63; 95% CI, 1.09-12.07, P = 0.035), but not ascites (P > 0.1). Relapse occurred in 32 (10%) patients: in 22 patients as borderline and in 10 patients as invasive tumor. Seven (70%) patients with invasive relapse died of disease. All patients with borderline relapses were successfully managed by second surgery, which in 80% was again conservative. Conclusions: Relapses in borderline ovarian tumor are uncommon, in 10% of patients. Invasive relapses are rare, only in 3% of patients, but often with fatal course irrespective of the treatment applied. The most important clinical risk factors of relapse are implants (FIGO II/III), FIGO Ic, and incomplete staging and this patients as well as patients with ascites should be closely followed. Relapses of borderline histology are easily detected and successfully managed by surgery.
引用
收藏
页码:1053 / 1061
页数:9
相关论文
共 50 条
  • [1] Long-term follow-up of women with borderline ovarian tumors
    Kehoe, S
    Powell, J
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1996, 53 (02) : 139 - 143
  • [2] Long-term Follow-up of Borderline Ovarian Tumors Clinical Outcome and Prognostic Factors
    Lazarou, Anastasia
    Fotopoulou, Christina
    Coumbos, Alexandra
    Sehouli, Jalid
    Vasiljeva, Jekaterina
    Braicu, Ioana
    Burger, Heinz
    Kuehn, Wolfgang
    [J]. ANTICANCER RESEARCH, 2014, 34 (11) : 6725 - 6730
  • [3] LONG TERM FOLLOW-UP OF BORDERLINE OVARIAN TUMORS
    Lazarou, Anastasia
    Fotopoulou, Christina
    Coumbos, Alexandra
    Sehouli, Jalid
    Vasiljeva, Jekaterina
    Braicu, Ioana
    Burger, Heinz
    Kuehn, Wolfgang
    [J]. ANTICANCER RESEARCH, 2014, 34 (10) : 6025 - 6026
  • [4] EVALUATION OF RISK FACTORS ASSOCIATED WITH RELAPSE AND RECURRENCE OF BORDERLINE OVARIAN TUMORS WITH NO INVASIVE IMPLANT
    Tounsi, N.
    Bouzaiene, H.
    Chemlali, M.
    Abdelwahed, N.
    Doghri, R.
    Hantouse, H.
    Bouazize, H.
    Hechiche, M.
    Ben Hassouna, J.
    Rahel, K.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1608 - 1608
  • [5] EPITHELIAL OVARIAN-TUMORS OF BORDERLINE MALIGNANCY - LONG-TERM FOLLOW-UP
    CASEY, AC
    BELL, DA
    LAGE, JM
    FULLER, AF
    NIKRUI, N
    RICE, LW
    [J]. GYNECOLOGIC ONCOLOGY, 1993, 50 (03) : 316 - 322
  • [6] Risk factors for postoperative recurrence of ovarian endometriosis: long-term follow-up of 358 women
    Li, Xiao-Yan
    Chao, Xiao-Pei
    Leng, Jin-Hua
    Zhang, Wen
    Zhang, Jun-Ji
    Dai, Yi
    Shi, Jing-Hua
    Jia, Shuang-Zheng
    Xu, Xiao-Xuan
    Chen, Si-Kai
    Wu, Yu-Shi
    [J]. JOURNAL OF OVARIAN RESEARCH, 2019, 12 (01)
  • [7] Risk factors for postoperative recurrence of ovarian endometriosis: long-term follow-up of 358 women
    Xiao-Yan Li
    Xiao-Pei Chao
    Jin-Hua Leng
    Wen Zhang
    Jun-Ji Zhang
    Yi Dai
    Jing-Hua Shi
    Shuang-Zheng Jia
    Xiao-Xuan Xu
    Si-Kai Chen
    Yu-Shi Wu
    [J]. Journal of Ovarian Research, 12
  • [8] Long-term follow-up after ovarian borderline tumor: Relapse and survival in a large patient cohort
    Lenhard, Miriam S.
    Mitterer, Stefanie
    Kuemper, Carolin
    Stieber, Petra
    Mayr, Doris
    Ditsch, Nina
    Friese, Klaus
    Burges, Alexander
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2009, 145 (02) : 189 - 194
  • [9] Risk factors for recurrence of ameloblastoma: a long-term follow-up retrospective study
    Au, S. W.
    Li, K. Y.
    Choi, W. S.
    Su, Y. X.
    [J]. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2019, 48 (10) : 1300 - 1306
  • [10] Correction of Hypertelorbitism: Evaluation of Relapse on Long-Term Follow-Up
    Wan, Derrick C.
    Levi, Ben
    Kawamoto, Henry
    Tanna, Neil
    Tabit, Christina
    do Amaral, Cassio Raposo
    Bradley, James P.
    [J]. JOURNAL OF CRANIOFACIAL SURGERY, 2012, 23 (01) : 113 - 117